Category: Federal Forum Posters
Purpose: This study will evaluate outcome benefits of veterans who are managed by diabetes shared medical appointments. This could lead to more effective use of appointment times and decrease wait time for veterans who are unable to see their primary care provider. The primary aim will evaluate changes from baseline in A1C in veterans with diabetes who are managed in shared medical appointments compared to being managed by usual pharmacist care. Secondary outcomes will evaluate changes in blood pressure, microalbumin/creatine ratio, low-density lipoprotein, triglycerides, total cholesterol and high-density lipoprotein from baseline during the shared medical appointment in comparison with pharmacist-based care.
Methods: This study will be submitted to the Institutional Review Board retrospective matched-comparison group design will be conducted of the Veterans with Type 2 Diabetes that were managed by shared medical appointments for a minimum of 6 months during August 1, 2015 to August 1st, 2018 with an A1C greater or equal to 7 percent. All data will be collected retrospectively using computerized patient record system. Veterans in the pharmacist managed care will be randomly selected for inclusion and chart review by matched comparison. The veterans in the study from the clinical pharmacist will be selected using a matched comparison. The review will include evaluating lab values of hemoglobin A1C, total cholesterol, low-density lipoprotein, high-density lipoprotein, triglycerides, microalbumin/creatinine ratio and blood pressure. Veterans will be excluded if they do not have appropriate labs to evaluate. Data will be analyzed using a paired t-test to compare outcomes during shared medical appointments and pharmacist led management of type 2 diabetes of veterans.
Results: not applicable
Conclusion: not applicable
Ganiat Animashawun– Pharmacy Resident, G.V. Sonny Montgomery Veterans Affairs Medical Center, Brandon, MS